Fighting neuroblastoma with TGFB receptorCatherine Bollard, M.B.Ch.B., M.D., and her team showed the potential efficacy of a novel cell therapy for treatment of pediatric patients with relapsed/refractory neuroblastoma. Their new approach allows them to engineer NK cells, expand and reinfuse them within a patient to enable them to fight neuroblastoma. |
viernes, 25 de octubre de 2019
Engineering TGFB receptor to enhance NK cells and fight neuroblastoma | Children's National
Engineering TGFB receptor to enhance NK cells and fight neuroblastoma | Children's National
![Advances in Oncology from Children's National](https://blogger.googleusercontent.com/img/proxy/AVvXsEgdSvNkd04n4DkiL-UDYqso9MFD6l6ySSJNb8ldVIH4yH1HArZPW_RnQ4SyWZ-xmDLmp447M1a7NOSNiHegEyAij8b5ynTY8VW2IhXg9GdBGlmMZIZUcTXDrbqSS_twhB3NCSTI0DWn8j8u167vT9TX4y4dsfRl3LIBA8yRXnj0-FiYq87LrStgH43U317qS42_js_pP2N4OZMSbSjrQw=s0-d-e1-ft)
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario